ArticlePloS one2018

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.

Holly Koblish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.